RxSight(US:RXST) Prnewswire·2025-09-08 21:12Core Points - Berger Montague PC is investigating potential securities fraud claims against RxSight, Inc. following a federal securities class action lawsuit [1][2] - The lawsuit alleges that RxSight faced "adoption challenges" and structural issues leading to declines in sales and utilization, and that the demand for its products was overstated [2] - It is claimed that RxSight is unlikely to meet its previously issued financial guidance for fiscal year 2025 [2] Company Information - RxSight, Inc. is publicly traded on NASDAQ under the ticker RXST [1] - The class period for the lawsuit is from November 7, 2024, to July 8, 2025, with a deadline for investors to seek lead plaintiff status by September 22, 2025 [3] - Berger Montague has a long history in securities class action litigation, having represented investors for over five decades [4]